Adagene (ADAG) Revenue & Revenue Breakdown
Adagene Revenue Highlights
Latest Revenue (Y)
$18.11M
Latest Revenue (Q)
$833.34K
Main Segment (Y)
Service
Main Geography (Y)
Service
Adagene Revenue by Period
Adagene Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $18.11M | 94.90% |
2022-12-31 | $9.29M | -8.67% |
2021-12-31 | $10.18M | 2019.85% |
2020-12-31 | $480.00K | - |
2019-12-31 | $480.00K | -68.24% |
2018-12-31 | $1.51M | - |
Adagene Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2023-12-31 | $833.34K | 104.31% |
2023-09-30 | $407.87K | -97.64% |
2023-06-30 | $17.30M | 100.00% |
2023-03-31 | $8.65M | 55.31% |
2022-12-31 | $5.57M | 107.40% |
2022-09-30 | $2.68M | -31.57% |
2022-06-30 | $3.92M | -57.83% |
2021-12-31 | $9.30M | 5356.65% |
2020-12-31 | $170.50K | 100.00% |
2020-09-30 | - | -100.00% |
2019-12-31 | $480.00K | - |
Adagene Revenue Breakdown
Adagene Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 20 |
---|---|
License | $225.00K |
Service | $398.88K |
Latest
Adagene Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 20 |
---|---|
License | $225.00K |
Service | $398.88K |
Latest
Adagene Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ADAG | Adagene | $18.11M | $833.34K |
ANAB | AnaptysBio | $17.16M | $30.02M |
JANX | Janux Therapeutics | $8.08M | $8.90M |
MOLN | Molecular Partners | $7.04M | $2.74M |
ANEB | Anebulo Pharmaceuticals | - | - |
RZLT | Rezolute | - | - |
ANTX | AN2 Therapeutics | - | - |
AVTE | Aerovate Therapeutics | - | - |
ELYM | Eliem Therapeutics | - | - |
ACRV | Acrivon Therapeutics | - | - |
PMVP | PMV Pharmaceuticals | - | - |
MLYS | Mineralys Therapeutics | - | - |